BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2
56535 results:

  • 1. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
    Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Radford M; Estcourt LJ; Sirotich E; Pitre T; Britto J; Watson M; Brunskill SJ; Fergusson DA; Dorée C; Arnold DM
    Cochrane Database Syst Rev; 2024 May; 5(5):CD011305. PubMed ID: 38780066
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.
    Heydari H; Iranikhah A; Ghasemi A; Mohammadbeigi A; Sadat-Mirei SA; Shams S; Kermani S
    BMC Infect Dis; 2024 May; 24(1):512. PubMed ID: 38778271
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
    Barajas Ordonez F; Zeller Y; Wolleschak D; Hinnerichs M; Rodríguez-Feria P; Mougiakakos D; Aghayev A; Kardas H; Mikusko M; Borggrefe J; Surov A
    Clin Nutr ESPEN; 2024 Jun; 61():274-280. PubMed ID: 38777443
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
    Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
    Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Santini V; Stahl M; Sallman DA
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432650. PubMed ID: 38768424
    [No Abstract]    [Full Text] [Related]  

  • 7. Cytoreductive chemotherapy in induction therapy plays a key role in the prognosis of patients with low-risk acute promyelocytic leukaemia.
    Zhu X; Tang F; Yu W; Zhao X; Qin Y; Jiang Q; Huang X; Jiang H
    J Cell Mol Med; 2024 May; 28(10):e18252. PubMed ID: 38766688
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Breaking barriers: supporting hematopoietic stem cell transplant program through collaborative radiation therapy service from a physically distant center.
    Pandit S; Sapkota S; Adhikari A; Karki P; Shrestha R; Jha DS; Prajapati R; Nyaichyai KS; Poudyal BS; Poudel B; Jha AK
    J Egypt Natl Canc Inst; 2024 May; 36(1):17. PubMed ID: 38764073
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cd(II)-based complex loaded with drug doxorubicin hydrogels against leukemia and reinforcement learning.
    Chen M; Chen D; Li G; Wu Y
    Sci Rep; 2024 May; 14(1):11350. PubMed ID: 38762628
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Interventional probability of causation (IPoC) with epidemiological and partial mechanistic evidence: benzene vs. formaldehyde and acute myeloid leukemia (AML).
    Cox LA; Thompson WJ; Mundt KA
    Crit Rev Toxicol; 2024 Apr; 54(4):252-289. PubMed ID: 38753561
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid leukemia.
    Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
    JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Association of serum protein electrophoresis with clinicopathological characteristics and its prognostic relevance in chronic lymphocytic leukaemia patients.
    Hameed A; Sajid N; Javaid RB; Ali N
    J Pak Med Assoc; 2024 Apr; 74(4):711-718. PubMed ID: 38751267
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors.
    Qiao XP; Wang XT; Wang S; Mu HX; Wang QS; Chen SW
    Bioorg Med Chem; 2024 May; 106():117752. PubMed ID: 38749341
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical Characteristics and Diagnosis of Ph-Positive Mixed Phenotype Acute leukemia.
    Zhang X; Li R; Zhang X; Li J; Li X; Chen J; Li H
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747916
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
    Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
    J Genet; 2024; 103():. PubMed ID: 38736250
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic leukemia.
    Verbeek MWC; van der Velden VHJ
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732101
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from
    Andrade KCR; Homem-de-Mello M; Motta JA; Borges MG; de Abreu JAC; de Souza PM; Pessoa A; Pappas GJ; de Oliveira Magalhães P
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732010
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2827.